[spacer image]
BD
[spacer image]
About Us
[spacer image]
Products
[spacer image]
News
[spacer image]
Events
[spacer image]
Contact Us
[spacer image]
[spacer image]
BD GeneOhm™ products assist in Transforming Patient Care™ by delivering rapid nucleic acid based diagnostic solutions. Our current assays for Group B Streptococcus (GBS), methicillin-resistant Staphylococcus aureus (MRSA), C. difficile toxin B gene (tcdB), and our combination assay for methicillin-resistant Staphylococcus aureus and Staphylococcus aureus (MRSA and SA), have been developed to improve patient outcomes by delivering cost-effective and rapid diagnostic solutions.
[spacer image] News & Events

[bullet] BD Completes Acquisition of HandyLab, Inc. »
[bullet] BD Announces Agreement to Acquire HandyLab, Inc. »
[bullet] BD Adds Surveillance Capability to Infectious Disease Portfolio »
[bullet] APIC Announces Launch of Online Education Center for Instant Access to Comprehensive Infection Prevention »
[bullet] BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays  »
[bullet] BD Announces Health Canada Licensing of Novel Molecular Assay for the Detection of Vancomycin Resistance Genes »
[bullet] BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections  »
[bullet] BD Selected to Participate in Premier QUEST Nationwide Hospital Collaborative to Reduce Healthcare-Associated Infections »
[bullet] BD Announces Health Canada Licensing of Novel Molecular Assay for Detection of Clostridium difficile Toxin B Gene  »
[bullet] BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections  »
[bullet] Preliminary Data from Pitt County Memorial Hospital Study Show Benefit of Active Surveillance on Reducing MRSA VAP Rates in Surgical ICU »
[bullet] BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates »
[bullet] BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures »
[bullet] BD Announces CE Marking of Rapid Molecular Test to Identify Superbug from Nasal and Wound Specimens »
[bullet] UCLH Study Demonstrates Rapid Patient Screening Could Cut MRSA Rates By Almost 40 Per Cent »
[bullet] BD Sponsors New Tool to Combat MRSA Infections in Hospitals »
[bullet] BD GeneOhm's Flagship Client, Evanston Northwestern Healthcare, Receives Prestigious Patient Safety Award from the NQF and the Joint Commission for its MRSA Prevention Program »
[bullet] BD Receives CE Mark Approval for Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures »
[bullet] BD Announces FDA 510(k) Submission of Two Hour Test to Identify Superbug in Patients with Positive Blood Cultures »
[bullet] Evanston Northwestern Healthcare Study Shows Benefit of Universal Surveillance (PDF) »
[bullet] Evanston Northwestern Healthcare Study Reveals Who is Most at Risk for Carrying MRSA (PDF) »
[spacer image] Learn More About...

[bullet] Healthcare-Associated Infections At A Glance (PDF) »

[bullet] BD GeneOhm™ Cdiff Assay Backgrounder (PDF) »

[bullet] BD Geneohm™ MRSA Assay At A Glance (PDF) »

[bullet] Benefits of Rapid Testing (PDF) »

[bullet] Key Research Papers Relevant to the BD GeneOhm™ MRSA Assay (PDF) »

[bullet] BD LabO™ Winter 2007 issue features HAIs (PDF) »

[spacer image]
[spacer image] BD GeneOhm™ Cdiff Now Available! »
 [spacer image]

[spacer image]


[spacer image] BD GeneOhm™ Webinar Series: Molecular Testing for HAIs in Practice - Setting New Standards »
 [spacer image]

[spacer image]


[spacer image] BD is proud to support Infection Preventionists worldwide as a 2009 APIC Strategic Partner »
 [spacer image]
[spacer image]
[spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image]
Site Map
Privacy | Terms & Conditions | Permission Request | Trademarks
BD Worldwide
BD
1 Becton Drive
Franklin Lakes, NJ USA 07417
201.847.6800
Unless otherwise noted, BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2009 BD